Tresmonte, Precilda T.
HRN: 20-19-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
CEFUROXIME 500MG (TAB)
08/31/2022
09/06/2022
ORAL
500mg
BID
Non Institutional Delivery
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes